Introduction
Tuberculosis, one of the leading causes of death worldwide, is caused primarily by the facultative intracellular bacterium Mycobacterium tuberculosis. Exacerbating the global problem of tuberculosis, the AIDS pandemic has resulted in an enormous population of HIV-infected persons highly susceptible to tuberculosis. Since the introduction of streptomycin in the 1950s, drugs have been available for the treatment of tuberculosis. However, with the exception of rifapentene, an analog of the preexisting drug rifampin, no new drugs have been licensed for use against tuberculosis in the past three decades, and strains of M. tuberculosis resistant to the major anti-tuberculosis drugs have been emerging worldwide. This has given new urgency to the search for new therapeutic modalities against tuberculosis.
In previous studies, using several M. tuberculosis gene transcripts as targets, we demonstrated that antisense technology is a feasible approach to combating this pathogen. In our first study, we established proof of concept by demonstrating that incubation of M. tuberculosis with antisense PS-ODNs directed against the M. tuberculosis glutamine synthetase I mRNA (glnA1 gene transcript) inhibited bacterial growth (1) . In a second study, we identified the three 30/32 kDa mycolyl transferases of M. tuberculosis as excellent targets for antisense technology, and demonstrated that the effectiveness of PS-ODNs is dependent upon a) the genomic location of the target gene (the best targets were located at the beginning of a multigene operon or in a single transcription unit); b) the location of the target sequence within the gene (targeting the 5' end of the transcript was most efficacious); and c) the propensity of the target region to form a stable secondary structure (a low propensity yielded a superior target) (2) .
In this study, using the three M. tuberculosis mycolyl transferase gene transcripts as a model target for the antisense approach, we have investigated the impact of modifying the ends of the PS-ODNs by the addition of hairpin and potential hairpin extensions. We hypothesized that the hairpin extensions might interfere with the functionality of the translation initiation start site. We demonstrate that the addition of such extensions at both the 5' and 3' ends of the PS-ODNs results in markedly increased efficacy.
Results
Transcript Target Sites and PS-ODN Selection. M. tuberculosis expresses and secretes three closely related mycolyl transferases which catalyze the transfer of mycolic acid from one trehalose 6-monomycolate molecule to another, resulting in the formation of free trehalose and trehalose 6,6'-dimycolate (TDM); TDM is subsequently incorporated into the cell wall (3) . The three 30/32 kDa enzymes, products of the M. tuberculosis genes fbpA, B, and C (3), are also known as Antigens 85A, B, and C, but will be referred to herein as the 32A, 30, and 32B proteins, respectively.
The 30, 32A, and 32B protein gene transcripts are promising targets for antisense therapy. The three transcripts are encoded by three different, unlinked, single operon genes: the fbpA gene which maps to position Rv3804c, the fbpB gene which maps to position Rv1886c, and the fbpC gene which maps to position Rv0129c of the M. tuberculosis genome (4). The three genes are constitutively expressed by M. tuberculosis throughout its growth in broth culture and in macrophages (5, 6) . The three proteins encoded by fbpA, B, and C are expressed in a molar ratio of 2:3:1, which is mirrored at the mRNA level.
In our previous study (2) on the inhibitory capacity of mycolyl transferase-specific antisense PS-ODNs, we demonstrated that the mRNA nucleotides encoding the first eight amino acids of each of the three enzymes, located at the initiation of translation, were the most effective target sites. In this study, we evaluated a new set of antisense PS-ODNs that had the same target sites but carried either one or two hairpin-like extensions of four or six base pairs in the form of fold-back structures at either their 5' and/or 3' ends ( Table 1 ). Critical to our rationale was recognition that precise tertiary interactions of the nascent initiation complex of proteins and aminoacylated tRNA occur at the ribosome, where the language of the gene is translated into that of the protein (7, 8) . We hypothesized that the hairpin structures may breathe at times and thus initiate interactions with other macromolecular participants in the translational initiation complex, inhibiting either their assembly or functionality.
Effect on M. tuberculosis Proliferation of Mycolyl Transferase Complex Specific
Antisense PS-ODNs with Hairpin Extensions. In a first set of experiments, we examined the inhibitory capacity of PS-ODNs containing one hairpin extension. These PS-ODNs, each targeting one of the transcripts of the mycolyl transferase complex, were administered individually or as a combination of all three. Each individual PS-ODN, added once at the start of the experiment, exerted a significant inhibitory effect on M. tuberculosis growth as evaluated by assaying colony-forming units (CFU) of M. tuberculosis during a six week growth period; however, the inhibitory capacity of these single hairpin containing PS-ODNs, as well as the combination of all three of these PS-ODNs, was no greater than that of unmodified PS-ODNs. The position of the hairpin extension, i.e. 5' or 3', had no observable influence on a PS-ODN's inhibitory capacity.
In a second set of experiments, we studied mycolyl transferase gene transcriptspecific PS-ODNs containing hairpin extensions at both ends of the PS-ODN. Each of the 5', 3'-modified PS-ODNs (HSP-ODNs) directed against an individual 30, 32A, or 32B protein gene transcript significantly inhibited M. tuberculosis growth compared with untreated cultures and cultures treated with mismatched PS-ODNs ( Fig. 1 ). As previously observed with unmodified PS-ODNs, the HPS-ODN directed against the 30 kDa mycolyl transferase gene transcript, which encodes the most abundant of the three mycolyl transferases, was the most effective. Remarkably, the HPS-ODN targeting the 7 30 kDa protein was almost as effective as the combination of three unmodified PS-ODNs targeting all three mycolyl transferases. Most importantly, the combination of three HPS-ODNs targeting all three mycolyl transferases was significantly more potent than the combination of three unmodified PS-ODNs targeting the three mycolyl transferases.
In three independent experiments with nearly identical results (a representative example is shown in Fig. 1 ), we observed growth inhibition by an individual HPS-ODN of up to 1 log unit and by the combination of all three HPS-ODNs of 1.5 to almost 2.0 log units, and in all cases, the HPS-ODNs were more potent than the unmodified PS-ODNs.
Mismatched PS-ODNs, whether hairpin-modified or not, had no inhibitory effect. In all of these experiments, the HPS-ODNs or PS-ODNs were added just once at the onset of the six-week culture period. To date, the inhibitory effect of the HPS-ODNs on M.
tuberculosis proliferation is the strongest we have observed for any antisense molecule after a single administration at the onset of the six-week culture period.
Stability of HPS-ODNs in M. tuberculosis Cultures.
For PS-ODNs to be effective over a six week culture period, their concentration must remain sufficiently high to inhibit proliferation. The results shown in Fig. 1 , where HPS-ODNs were added once at the beginning of the growth period, suggested that the HPS-ODNs were fairly stable in the culture medium. To evaluate their stability, we assayed their concentration in the culture medium weekly (Fig. 2) . The fall-off in HPS-ODN concentration was somewhat biphasic, tuberculosis by gel electrophoresis and immunoblotting, we found that the expression levels greatly decreased in the presence of HPS-ODNs ( Fig. 3 ). Each HPS-ODN acted against its cognate gene transcript, thereby causing a decrease in expression of the encoded protein while leaving the expression of the other two components of the mycolyl transferase complex unchanged. Consistent with an earlier finding that the expression of the three constitutively expressed proteins correlates well with their transcription levels (5), we observed that the HPS-ODNs targeting the 32A or 32B proteins caused a greater decrease in protein expression (~80%) than the HPS-ODN targeting the 30 kDa protein (~ 70% decrease), presumably because the bacteria contain more 30 kDa protein gene-specific mRNA than 32A or 32B specific mRNA.
Assuming similar uptake and hybridization kinetics for each of the three HPS-ODNs, we can conclude that the ratio of protein gene transcript-specific HPS-ODNs to target transcripts is a little less favorable for the 30 kDa protein gene than that for the other two protein genes. The combination of all three HPS-ODNs reduced the expression levels of the three proteins to ≤ 10% of their normal levels ( Fig. 3 ).
As a control for specificity of inhibition of protein expression, we assayed the effect of the anti-mycolyl transferase-specific HPS-ODNs on the unrelated enzyme glutamine synthetase. Activity of the enzyme was assayed by the transfer reaction (9, As treatment with mycolyl transferase-specific HPS-ODNs depletes the M. tuberculosis culture of mycolyl transferases, we investigated whether the addition of exogenous mycolyl transferase to HPS-ODN treated cultures could rescue the bacteria and allow normal growth. We estimated that the untreated cultures produced ~ 1-2 μg of the 30 kDa mycolyl transferase over a six week period. We added 20 μg of purified recombinant 30 kDa protein (11) , an amount in great excess of that produced by an untreated culture, to HPS-ODN-treated cultures; the protein was added once at the beginning of the six-week culture period or weekly. When the 30 kDa protein was added only once at the start of the assay, it had no impact on the growth of the cultures treated with either a single HPS-ODN targeting only the 30 kDa mycolyl transferase or a combination of three HPS-ODNs targeting each of the mycolyl transferases. When the 30 kDa protein was added weekly to the cultures, there was a slight enhancement of growth both in cultures treated with the single HPS-ODN and cultures treated with the three HPS-ODNs in combination (data not shown). Hence, the cultures could only be slightly rescued by the addition of exogenous mycolyl transferase.
Effect of 30, 32A, and 32B Protein Gene Specific HPS-ODNs on the
Corresponding Gene Transcripts. The reduction we measured for the expression of the three mycolyl transferases could be caused by a decrease in synthesis of the specific transcripts and/or by a decrease in mRNA translation. We performed Northern hybridizations for each individual transcript with total RNA isolated from four and six week old cultures and biotinylated gene probes to distinguish between these two possibilities. Using RNA extracted from equal numbers of bacteria, we observed that the levels of mycolyl transferase -specific mRNA were greatly diminished in treated cultures compared with untreated cultures (Fig. 4) , as was the case with the expression of the three mycolyl transferase proteins. However, in contrast to the results obtained for the protein expression levels, the 32 A and 32B protein gene specific HPS-ODNs, when administered individually, reduced the levels of the corresponding transcripts to ~ 10%, while the 30 protein gene specific HPS-ODN reduced the level of the corresponding transcript to ~ 1%, although this transcript is normally present in concentrations equal to or higher than the 32A and 32 B protein gene transcripts. This was a remarkable result as it meant that the 30 protein gene transcript is present at a 10-fold lower concentration than the other two transcripts in the treated cultures and that this transcript had to be translated much more frequently than the other two transcripts to maintain a 30 kDa protein level that was ~ 1.5 times the steady state level of the 32A + 32B kDa proteins in the HPS-ODN treated cultures ( Fig. 3 ). All hybridizations were very specific as the 30, 32A, and 32B transcript probes did not detect other RNA species, treatment with ribonucleases abolished all signals, and unrelated probes (glnA1) did not hybridize to the 30, 32A, or 32B protein gene transcripts (not shown).
The level of the unrelated, constitutively expressed mpt64 gene transcript (Rv1980c, encoding a secreted 23.5 kDa protein), assayed as a control RNA, did not change under any of the culture conditions (not shown). Since first demonstrating that antisense PS-ODNs could inhibit M. tuberculosis, we have sought to improve the technology in two major ways. First, we have explored a variety of M. tuberculosis targets for the technology. These efforts culminated in our identifying the 5' region of the transcripts of the mycolyl transferase complex genes as particularly good targets, as discussed further below. Second, we have sought to improve the efficacy of the PS-ODNs against their targets via a variety of approaches.
Isoniazid (INH) and HPS-ODNs
Prior to this study, we assessed nearly 10 different modifications of PS-ODNs aimed at enhancing their uptake into bacteria, their intracellular stability, or their capacity to block the translation initiation complex. These modifications have included linking an antibiotic (amikacin, puromycin, ethambutol, or cycloheximide) to the PS-ODN, adding a series of 1-5 guanine nucleotides or 2 uracil nucleotides to the PS-ODN, adding a 2' Omethyl group to selected nucleotides, or adding aliphatic side chains to selected nucleotides. However, none of these modifications significantly improved the efficacy of the PS-ODNs. In addition, in previous studies, we co-administered antibiotics with the PS-ODNs in an attempt to "soften up" the mycobacterial cell wall and thereby enhance the uptake of PS-ODNs; however, the effect of the antibiotics was only additive with that of the PS-ODNs and not synergistic (1) . The addition of hairpin extensions at the 5' and 3' ends of the PS-ODNs is the first modification of PS-ODNs to enhance their potency substantially.
The mycolyl transferase gene transcripts are the best antisense target of nearly 30 different targets of M. tuberculosis that we have investigated. As a drug target, the mycolyl transferase complex has several advantages. First, from a genetic perspective, the DNA sequences encoding the mycolyl transferases do not show homology to any eukaryotic sequences; even the similarities to the few microbial species related to mycobacteria are sparse. Second, from a biochemical perspective, the enzymes perform a reaction that is specific for mycobacteria and there are no bypass reactions for the synthesis of the essential cell wall component trehalose dimycolate. Third, from a technical perspective, each of the three genes fulfills the criteria for an ideal antisense technology target: (i) each gene is located in a single cistron unit with its specific promoter and terminator regions and (ii) each gene contains a region very near the 5' end of its encoded transcript that has a very low propensity to assume a stable secondary structure.
Tuberculosis is an infectious disease that is treated with multiple antibiotics to prevent the emergence of resistant organisms. Antisense technology lends itself well to this strategy since it is conducive to the simultaneous administration of a combination of PS-ODNs directed against multiple targets. As with any drug, mycobacteria could potentially develop resistance to specific PS-ODNs by nucleotide changes in the target site. Moreover, mycobacteria could potentially develop a general resistance to PS-ODNs, for example via mutations that prevent the uptake of PS-ODNs into the bacterial cell. Hence, PS-ODNs might best be administered in combination with conventional antibiotics. In this regard, it was encouraging to find in this study that HPS-ODNs not only increased the susceptibility of M. tuberculosis to the leading antituberculous drug INH, but they acted synergistically with INH in inhibiting M. tuberculosis multiplication.
A milestone reached in the present study was the demonstration that HPS-ODNs could inhibit growth of M. tuberculosis inside macrophages. M. tuberculosis is an intracellular pathogen that resides and multiplies within a phagosome inside a host mononuclear phagocyte. Our study demonstrates that antisense molecules are capable of reaching the mycobacteria in their intracellular niche. In this regard, it is encouraging that in vivo studies have shown that PS-ODNs can be taken up by mononuclear phagocytes (16) . Important challenges remain for the application of antisense technology to the treatment of tuberculosis. For example, the efficacy of antisense molecules against M. tuberculosis in a relevant animal model has yet to be demonstrated. As the capacity of HPS-ODNs to inhibit M. tuberculosis within macrophages in vitro is still modest, undoubtedly, greater improvement in their potency will be necessary to achieve in vivo efficacy.
Materials and Methods

PS-ODN Selection and Preparation.
All target sites encompassed the first 8 codons of the transcripts of the fbpA (Rv3804c), fbpB (Rv1886c), and fbpC (Rv0129c) genes, referred to herein as the 32A, 30, and 32B protein genes, respectively. The PS-ODNs' DNA sequences and their target sites are described in Table 1 tuberculosis were set up as described above. After 4 weeks and 6 weeks, 1 ml of each culture was centrifuged to pellet the bacteria, and each sample culture supernate was concentrated in an Amicon Diaflo unit to 100 µL. One half of each concentrated culture filtrate was subjected to sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS-PAGE) to analyze each protein profile; the remainder of each sample was used for several immunoblots for which the electrophoresed proteins (derived from the equivalent of 5 x 10 7 CFU of M. tuberculosis) were transferred to nylon membranes, probed with 30/32 kDa protein-specific immunoglobulins at dilutions of 1:100,000 and reacted with horse radish peroxidase (HRPO) coupled secondary antibodies at a dilution of 1:50,000. The immunocomplexes were detected with an HRPO substrate kit (Pierce) and exposure to X-ray film (Kodak) for 10 -30 sec at room temperature. The images were digitized using Photoshop 5.5 software (Adobe Systems) and proteinspecific bands were quantitated densitometrically using NIH Image 1.62 software. were first cultured in broth and then on 7H11 plates for 10 days at 37 0 C in a 5% CO 2 -20 95% air atmosphere before being collected, washed, and diluted to the concentration required. At 3 h, 2 days, and 5 days after infection, the THP-1 cell cultures were lysed by the addition of 0.1% SDS and culture aliquots were serially diluted, plated on 7H11 agar, and incubated for 2 weeks at 37 0 C in a 5% CO 2 -95% air atmosphere for the enumeration of CFU. CFU from culture aliquots taken 3 h after the infection were used to determine the infection rate (8 -12%) and the data point at time "0 days".
Expression
Statistics.
Means were compared across treatment groups within an experiment using factorial analysis of variance (ANOVA) methods. were added once at the start of the growth period. After four and six weeks of growth, total RNA was isolated from treated and untreated cultures, subjected to Northern blots, and probed with biotin-labeled DNA fragments from the 5' ends of the 30, 32A, and 32B protein gene coding regions. RNA -DNA hybrids were visualized after horse radish peroxidase reaction by exposure to X-ray film (Kodak) for 30 min at room temperature. for each of the data points at 5 days was 0.007 logs. Differences in CFU at 5 d between the group treated with 3 HPS-ODNs and either the untreated group or the group treated with mismatched HPS-ODNs were statistically significant at both MOI = 1 and 10 (P < 0.0001 by ANOVA for all comparisons). In a second experiment that was similar to this one except that it lacked the group treated with mismatched HPS-ODNs and the cultures were assayed in duplicate, differences in CFU at 5 d between the group treated with HPS-ODNs and the untreated group were similar in magnitude to this experiment and statistically significant (P = 0.02 for MOI = 1 and P = 0.002 for MOI = 10). Week Colony Forming Units (CFU) per ml 
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